|
Volumn 37, Issue 3, 2001, Pages 215-217
|
Hepatitis B vaccine: Risks and benefits of universal neonatal vaccination
|
Author keywords
Adverse events; Eradication; Hepatitis B; Neonate; Vaccines
|
Indexed keywords
HEPATITIS B VACCINE;
PRESERVATIVE;
THIOMERSAL;
COST EFFECTIVENESS ANALYSIS;
DRUG INDUCED DISEASE;
ENDEMIC DISEASE;
FEVER;
HEPATITIS B;
HIGH RISK POPULATION;
HUMAN;
MULTIPLE SCLEROSIS;
NEWBORN;
NEWBORN CARE;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
VACCINATION;
VIRUS TRANSMISSION;
AUSTRALIA;
HEPATITIS;
HEPATITIS B VACCINES;
HUMANS;
IMMUNIZATION SCHEDULE;
INFANT WELFARE;
INFANT, NEWBORN;
RISK ASSESSMENT;
VACCINATION;
WORLD HEALTH;
WORLD HEALTH ORGANIZATION;
|
EID: 0034931854
PISSN: 10344810
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1754.2001.00639.x Document Type: Review |
Times cited : (9)
|
References (29)
|